losartan has been researched along with bilirubin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Kalk, JF; Klein, CP; Schneider, AW | 1 |
| Badowski, R; Cieślik, P; Haczkiewicz, P; Hefczyc, J; Hrycek, A; Scieszka, J | 1 |
| Calès, P; Chappard, D; Croquet, V; Douay, O; Gallois, Y; Moal, F; Oberti, F; Roux, J; Veal, N; Vuillemin, E; Wang, J | 1 |
| Bakker, SJ; Cooper, ME; de Zeeuw, D; Deetman, PE; Lambers Heerspink, HJ; Lewis, JB; Navis, G; Riphagen, IJ | 1 |
| Agarwal, A; Hull, TD | 1 |
1 review(s) available for losartan and bilirubin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
2 trial(s) available for losartan and bilirubin
| Article | Year |
|---|---|
Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Bilirubin; Female; Hemodynamics; Humans; Hypertension, Portal; Kidney; Liver; Liver Cirrhosis; Losartan; Male; Middle Aged; Weight Gain | 1999 |
[Estimation of blood pressure, selected biochemical parameters and indices of left ventricular heart function in patients with mild or moderate essential hypertension treated with potassium losartan].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Bilirubin; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cholesterol; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Potassium; Sodium; Time Factors; Treatment Outcome; Triglycerides; Uric Acid; Ventricular Function, Left | 2001 |
3 other study(ies) available for losartan and bilirubin
| Article | Year |
|---|---|
Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.
Topics: Alanine Transaminase; Alkaline Phosphatase; Angiotensin Receptor Antagonists; Animals; Bile Ducts; Bilirubin; Carbon Tetrachloride; Diuresis; Dose-Response Relationship, Drug; Hemodynamics; Hypertension, Portal; Ligation; Liver; Liver Cirrhosis; Losartan; Rats; Rats, Sprague-Dawley; Splanchnic Circulation | 2002 |
Bilirubin and progression of nephropathy in type 2 diabetes: a post hoc analysis of RENAAL with independent replication in IDNT.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Bilirubin; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Irbesartan; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Retrospective Studies; Tetrazoles | 2014 |
Bilirubin: a potential biomarker and therapeutic target for diabetic nephropathy.
Topics: Bilirubin; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Irbesartan; Losartan; Male; Tetrazoles | 2014 |